Atlas Trials

Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers

Clinical trial NCT01217814 · TERMINATED

Trial details

NCT number
NCT01217814
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2010-11-01
Primary completion
2011-09-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.